Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Prominent cell and gene therapy vendors in 2023

By Brian Buntz | March 15, 2023

Prominent cell and gene therapy vendorsIn recent years, the cell and gene therapy market has grown at a rapid clip. The momentum is likely to continue. According to Vision Research Reports, the global cell and gene therapy market size could hit around $42.56 billion by 2030, growing at a CAGR of 39% from 2022 to 2030.

The burgeoning demand in the industry, along with an increasing number of FDA-approved therapies, is also fueling the growth of cell and gene therapy vendors offering tools and services for product development and manufacturing.

The following table includes notable vendors and suppliers active in the call and gene therapy marketplace. This curated selection of companies includes a brief overview of their focus areas.

We have a separate feature focused on companies with prominent cell and gene therapy development efforts.

Company Name Description Notable partnerships Founded Headquarters
10X Develops single-cell genomics and transcriptomics technology. Joined forces with Illumina for single-cell analysis. 2012 Pleasanton, California
AGC Biologics Offers cell line development, process development, and GMP manufacturing services for cell and gene therapies. Teamed up with Novavax for COVID-19 vaccine production. 2016 Bothell, Washington
Akoya Biosciences Develops multiplexed imaging technology for research and drug discovery. Has partnered with Biotechne’s ACD, Agilent, Enable Medicine and Keyence. 2015 Marlborough, Massachusetts
Aldevron Provides plasmid DNA, RNA and protein production services for gene therapy products. Worked with Sarepta Therapeutics for gene therapy production. 1998 Fargo, North Dakota
Avectas Develops non-viral cell engineering technology for the development of cell therapies. Collaborated with CCRM and the Canadian government for cell engineering technologies. 2011 Kildare, Ireland
Bluebird bio Develops and manufactures gene therapies for the treatment of rare genetic diseases. Worked with Bristol Myers Squibb for gene therapy development and commercialization. 1992 Cambridge, Massachusetts
Brammer Bio (Thermo Fisher Scientific) Offers process development, clinical manufacturing, and regulatory support for gene and cell therapies Allied with Amicus Therapeutics on gene therapy development. 2016 Cambridge, Massachusetts
Catalent Has a comprehensive cell therapy portfolio with expertise across various cell types. Teamed up with Moderna for COVID-19 vaccine production. 2007 Somerset, New Jersey
Cellares Offers a flexible and scalable cell and gene therapy manufacturing platform known as the Cell Shuttle. Worked with Fred Hutchinson Cancer Research Center and Poseida Therapeutics. 2020 Cambridge, Massachusetts
CEVEC Pharmaceuticals Provides cell line development services for gene therapy products. Allied with Roche on gene therapy. 2004 Cologne, Germany
Charles River Laboratories Provides discovery and development services for cell and gene therapies, and provides cell line development services for gene therapy products. Working with Purespring Therapeutics, a gene therapy company focused on kidney diseases. The partnership centers on plasmid DNA CDMO services. 1947 Wilmington, Massachusetts
Codexis Offers enzyme engineering services for the production of gene therapy vectors. Partners include Merck & Co., GSK, Novartis and Takeda. 2002 Redwood City, California
CRISPR Therapeutics Develops gene therapies using CRISPR-Cas9 gene editing technology. Assisted Vertex Pharmaceuticals with gene therapy development and commercialization. 2013 Cambridge, Massachusetts
Curate Biosciences Launched the first microfluidics-based cell processing platform, improving the efficiency of patient apheresis and T-cell isolation, leading to better therapies and less engineering/manipulation needed down the line. Working with City of Hope on cancer research. Other partners include academic centers, biotechs and CDMOs. Has venture financing from Amgen Ventures, Vensana Capital and other prominent health care investors. 2019 South San Francisco, California
Fujifilm Cellular Dynamics Develops and manufactures human cells used in cell therapy development, and other applications. Collaborators include Axcelead Drug Discovery Partners, Axxam, PhenoVista Biosciences and Nanion Technologies. 1992 Madison, Wisconsin
GeneWerk Provides analytical services for the characterization of gene therapy vectors. Allied with RECOMB, an EU-funded research consortium. 2017 Heidelberg, Germany
GenScript Offers gene synthesis, molecular biology, and bio-manufacturing services for gene and cell therapies. Multiple partnerships for biologic, cancer immunotherapy, and CAR-T cell therapy development. Applied Cells is one recent partner. 2002 Piscataway, New Jersey
Lonza The company’s Cocoon Platform is a closed, automated, and modular system for the manufacturing of cell and gene therapies. Teamed up with Moderna for COVID-19 vaccine production. 1897 Basel, Switzerland
MaxCyte Offers electroporation technology for the development of cell therapies. Has partnered with Allogene, Kite, Vertex, Caribou Biosciences, CRISPR Therapeutics and Editas Medicine. 1998 Gaithersburg, Maryland
MeiraGTx Develops gene therapies for the treatment of rare genetic diseases. Worked with Janssen Pharmaceuticals for gene therapy development and commercialization. 2015 New York City
Miltenyi Biotec Offers cell and gene therapy products, as well as clinical and research solutions, including cell processing systems, cell isolation, and GMP manufacturing services Allied with the EMBL Advanced Training Centre Corporate Partnership Programme to further life sciences research. 1989 Bergisch Gladbach, Germany
Minaris Regenerative Medicine A leading global contract development and manufacturing organization (CDMO) dedicated to the production of cell and gene therapy products. Working with LIfT BioSciences, which is developing an allogeneic neutrophil progenitor-derived cell therapy. Also has manufacturing partnership with Mendus AB. 2017 Ottobrunn, Germany
Mission Bio Develops single-cell sequencing technology for research and drug discovery. Worked with Allogene, Avrobio, Bluebird Bio, Cellectis, CRISPR Therapeutics, CSL Behring, Genentech, Graphite Bio, Homology Medicines and Poseida. 2014 South San Francisco, California
Mustang Bio Develops and manufactures cell and gene therapies for the treatment of cancer and genetic diseases. Teamed up with City of Hope for gene therapy development and commercialization. 2015 Waltham, Massachusetts
Nanostring Develops and manufactures genetic analysis technology. Has partnerships with Bioteche’s ACD, Leica Biosystems and Abcam. 2003 Seattle, Washington
Ori Biotech Offers a platform for cell and gene therapy manufacturing process development and optimization. Collaborates with the Cell Therapy Manufacturing Center (CTMC). 2015 London, UK
Oxford Biomedica Offers lentiviral vector development, process development, and GMP manufacturing services for gene and cell therapies. Worked with Novartis for gene therapy development and production. 1995 Oxford,UK
Pluristem Therapeutics Develops allogeneic cell therapies for the treatment of inflammatory and ischemic diseases. Worked with NASA to study microgravity’s effects on cell therapy. 2001 Haifa, Israel
Precision BioSciences Develops gene therapies using its ARCUS gene editing technology. Allied with Servier for gene therapy development and commercialization. 2006 Durham, North Carolina
Regenxbio Provides gene therapy vector platforms and manufacturing services Partnership with AbbVie on gene therapy for eye care. 2008 Rockville, Maryland
Resolve Biosciences Offers a platform for the automated manufacturing of cell therapies. Resolve Biosciences has become a member of EMBL’s Corporate Partnership Programme (CPP). Additionally, they have announced a co-development collaboration with Zeiss to improve the highest-resolution view of subcellular spatial biology. 2013 South San Francisco, California
Samsung Biologics Offers cell line development, process development, and GMP manufacturing services for cell and gene therapies. Has worked with Moderna, GSK, Eli Lilly and AstraZeneca. 2011 Incheon, South Korea
Sangamo Therapeutics Develops gene therapies using zinc finger nuclease gene editing technology. Worked with Pfizer for gene therapy development and commercialization. 1995 Brisbane, California
Sarepta Therapeutics Develops gene therapies for the treatment of genetic diseases. Collaborates with Roche for gene therapy development and commercialization. 1980 Cambridge, Massachusetts
Spark Therapeutics (Roche) Develops and manufactures gene therapies. Working with Horae Gene Therapy Center, Neurochase and CombiGene. 2013 Philadelphia, Pennsylvania
Synthego Offers gene editing tools, including CRISPR reagents and synthetic RNA for research and therapeutic applications. Has alliances with NIST, Alliance for Regenerative Medicine, CMaT, CIRM and NIMBL. 2012 Redwood City, California
Terumo BCT Presented their first data since launching Quantum Flex, showing the capability to rapidly expand extracted T cells to make a dose, and its scalability for early research up through clinical batches. Working with Queen’s University Belfast on a Knowledge Transfer Partnership (KTP). 1964 Lakewood, Colorado
Thermo Fisher Scientific Provides GMP plasmids, viral vectors, and cell and gene therapy manufacturing services through its Gibco, Aldevron, and Brammer Bio brands. Partnership with Hengrui Therapeutics for the development and commercialization of cancer immunotherapies. 1902 Waltham, Massachusetts

Filed Under: Cell & gene therapy, Special Feature
Tagged With: 10X, AGC Biologics, Akoya Biosciences, Aldevron, Avectas, Bluebird Bio, Brammer Bio (Thermo Fisher Scientific), Catalent, cell therapy, Cellares, CEVEC Pharmaceuticals, Charles River Laboratories, Codexis, Cognate BioServices, CRISPR Therapeutics, Curate Biosciences, Fujifilm Cellular Dynamics, gene therapy, GeneWerk, GenScript, Lonza, market size, MaxCyte, MeiraGTx, Miltenyi Biotec, Minaris Regenerative Medicine, Mission Bio, Mustang Bio, Nanostring, Ori Biotech, Oxford Biomedica, Pluristem Therapeutics, Precision Biosciences, Regenxbio, Resolve, Samsung Biologics, Sangamo Therapeutics, Sarepta Therapeutics, Spark Therapeutics (Roche), Synthego, Terumo BCT, Thermo Fisher Scientific, vendors
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

How Thermo Fisher’s KingFisher PlasmidPro crunches hours of plasmid prep to 5 minutes hands-on
Can space help heal hearts? ISS study charts new path for stem cell therapy
MIT team designs gene circuits for tighter control in gene therapy study
Meet STITCHR, the retrotransposon-based gene editor that enables large, scarless DNA insertions
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE